Clinical Trial Update: A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect on albuminuria after 24 weeks of treatment with valsartan, benazepril, or their combination in patients with hypertension an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Benazepril (Benazepril)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension, Diabetic Nephropathy | Phase 4 | Status: TERMINATED